Evidence map›Paper›PMID 39355026›Full record

ArticleFrontiers in nuclear medicine2023

Case report: Peptide receptor radioligand therapy in metastatic pediatric neuroendocrine tumors.

Khanyisile Hlongwa, Olumayowa Kolade, Abdulilah Alnabulsi, Rachelle Steyn, Anita Brink, Vikas Prasad, Stuart More

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in nuclear medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Safety and dosimetry of [European journal of nuclear medicine and molecular imaging · 2025
    Trial
  2. [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Khanyisile HlongwaDepartment of Nuclear Medicine, Red Cross Children's Hospital and Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Olumayowa KoladeDepartment of Nuclear Medicine, Red Cross Children's Hospital and Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Abdulilah AlnabulsiDepartment of Nuclear Medicine, Red Cross Children's Hospital and Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Rachelle SteynDepartment of Nuclear Medicine, Red Cross Children's Hospital and Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Anita BrinkDepartment of Nuclear Medicine, Red Cross Children's Hospital and Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Vikas PrasadDepartment of Nuclear Medicine, Red Cross Children's Hospital and Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Stuart MoreDepartment of Nuclear Medicine, Red Cross Children's Hospital and Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroendocrine tumors (NETs) are not commonly diagnosed in children. Metastatic NETs tend to have poor outcomes, and this is seen in adult and pediatric populations. The role of somatostatin receptor imaging using [

Indexed as

DOTA-TATEneuroendocrine tumorpediatricsPRRTtheranostics (combined therapeutic and diagnostic technology)

Identifiers

PMID39355026
PMCPMC11440991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.